FDA communications refers to the regulatory communications obligations and strategies surrounding the U.S. Food and Drug Administration — including product labeling compliance, health-claim substantiation, recall announcements, and responses to FDA enforcement actions.

Labeling and Claims

The FDA regulates what food and beverage brands can say on packaging and in marketing materials. Structure/function claims ("supports immune health") are permitted with proper disclaimers. Health claims ("reduces the risk of heart disease") require significant scientific agreement and FDA authorization. Disease claims are prohibited for foods and dietary supplements without FDA approval.

Recall Communications

When the FDA initiates or a company voluntarily issues a product recall, the communications response must be immediate, transparent, and comprehensive. The press release includes: what product is affected, why it's being recalled, what the risk is, what consumers should do, and how to get a refund. Speed and clarity reduce both health risk and reputational damage. See Recall Communications.

Warning Letters

An FDA Warning Letter is a public enforcement action — it appears on the FDA website and is picked up by trade and consumer media. The communications response must acknowledge the issue, describe corrective actions, and demonstrate compliance. Ignoring or disputing a Warning Letter publicly escalates the story.

PR Guardrails

PR teams in food and beverage must understand FDA regulatory language. Every press release, social post, and influencer brief should be reviewed for claims compliance before distribution. A single unauthorized health claim in an influencer post can trigger an FDA enforcement action.